Astroscape: a Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients with TSC or FCD Type II
Phase 1
Recruiting
- Conditions
- Focal Cortical DysplasiaTuberous Sclerosis Complex
- Interventions
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- GRIN Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06392009
- Locations
- ๐ฆ๐บ
Queensland Children Hospital, South Brisbane, Australia
๐ง๐ชUniversitair Ziekenhuis Antwerpen (UZA), Antwerp, Belgium
๐ง๐ชUniversity Hospitals Leuven, Pediatric Neurology, Leuven, Belgium
Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- GRIN Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05818943
- Locations
- ๐ณ๐ฑ
UMC Utrecht - Wilhelmina Kinderziekenhuis, Polikliniek Kinderneurologie, Utrecht, Netherlands
๐ช๐ธUniversitat de Barcelona - Hospital Sant Joan de Deu Barcelona (HSJDB), Barcelona, Spain
๐บ๐ธMid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath